CJC-1295 No DAC

CJC-1295 No DAC is a modified synthetic analog of Growth Hormone Releasing Hormone (GHRH 1-29) engineered for laboratory research involving pulsatile growth hormone signaling and peptide-receptor interaction pathways. Unlike DAC-modified versions, CJC-1295 No DAC is commonly studied for its shorter active duration and more controlled release characteristics in peptide research models.

In controlled laboratory environments, researchers investigate CJC-1295 No DAC for its interaction with pituitary GHRH receptors and downstream growth hormone/IGF-1 signaling cascades. Its structure and activity profile have made it a widely utilized compound in endocrine pathway research, metabolic regulation studies, recovery-related signaling investigations, and body composition models.

Research Focus Areas

• Pulsatile growth hormone release studies
• GHRH receptor binding and signaling research
• IGF-1 pathway investigations
• Metabolic and nutrient partitioning models
• Recovery and regenerative signaling pathways
• Endocrine communication studies

Product Specifications

• Compound: CJC-1295 No DAC
• Sequence Base: Modified GHRH (1-29) Analog
• Format: Lyophilized Powder
• Purity: Research Grade
• Stability: Intended for controlled laboratory handling and storage
• Intended Use: Research & Laboratory Use Only

Handling & Storage

• Store in a cool, dry environment
• Protect from direct light and excessive heat
• For laboratory handling by qualified professionals only

⚠️ Disclaimer:
This product is intended strictly for laboratory and analytical purposes only. Not for human consumption, therapeutic applications, veterinary use, or diagnostic procedures.